{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:20:00Z","timestamp":1756992000923},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00464-019-06916-6","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T22:51:30Z","timestamp":1569538290000},"page":"1561-1572","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A budget impact analysis of a magnetic sphincter augmentation device for the treatment of medication-refractory mechanical gastroesophageal reflux disease: a United States payer perspective"],"prefix":"10.1007","volume":"34","author":[{"given":"John","family":"Pandolfino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lipham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarpreet","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Ferko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana A.","family":"Qadeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"6916_CR1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40273-014-0164-8","volume":"32","author":"AJ Gawron","year":"2014","unstructured":"Gawron AJ, French DD, Pandolfino JE, Howden CW (2014) Economic evaluations of gastroesophageal reflux disease medical management. Pharmacoeconomics 32:745\u2013758","journal-title":"Pharmacoeconomics"},{"key":"6916_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304269","author":"HB El-Serag","year":"2013","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J (2013) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2012-304269","journal-title":"Gut"},{"key":"6916_CR3","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1007\/s00464-015-4635-6","volume":"30","author":"JL Reynolds","year":"2016","unstructured":"Reynolds JL, Zehetner J, Nieh A, Bildzukewicz N, Sandhu K, Katkhouda N, Lipham JC (2016) Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus laparoscopic Nissen fundoplication for the treatment of GERD. Surg Endosc 30:3225\u20133230","journal-title":"Surg Endosc"},{"key":"6916_CR4","first-page":"42","volume":"25","author":"D Gregory","year":"2016","unstructured":"Gregory D, Scotti D, Buck D, Triadafilopoulos G (2016) Budget impact analysis to estimate the cost dynamics of treating refractory gastroesophageal reflux disease with radiofrequency energy: a payer perspective. Managed care (Langhorne, Pa) 25:42\u201350","journal-title":"Managed care (Langhorne, Pa)"},{"key":"6916_CR5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ajg.2011.113","volume":"106","author":"S Ngamruengphong","year":"2011","unstructured":"Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K (2011) Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies. Am J Gastroenterol 106:1209","journal-title":"Am J Gastroenterol"},{"key":"6916_CR6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","volume":"107","author":"CS Kwok","year":"2012","unstructured":"Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK (2012) Risk of clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 107:1011","journal-title":"Am J Gastroenterol"},{"key":"6916_CR7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2036.2010.04406.x","volume":"32","author":"H El-Serag","year":"2010","unstructured":"El-Serag H, Becher A, Jones R (2010) Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther 32:720\u2013737","journal-title":"Aliment Pharmacol Ther"},{"key":"6916_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2165\/11595480-000000000-00000","volume":"31","author":"S Toghanian","year":"2011","unstructured":"Toghanian S, Johnson DA, St\u00e5lhammar N-O, Zerbib F (2011) Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy. Clin Drug Invest 31:703\u2013715","journal-title":"Clin Drug Invest"},{"key":"6916_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cgh.2012.12.006","volume":"11","author":"JE Richter","year":"2013","unstructured":"Richter JE (2013) Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin Gastroenterol Hepatol 11:465\u2013471","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6916_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/gastro\/gou061","volume":"3","author":"CR Subramanian","year":"2014","unstructured":"Subramanian CR, Triadafilopoulos G (2014) Refractory gastroesophageal reflux disease. Gastroenterol Rep 3:41\u201353","journal-title":"Gastroenterol Rep"},{"key":"6916_CR11","unstructured":"Food and Drug Administration (FDA) (2012) LINX Reflux Management System - Instructions for Use"},{"key":"6916_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.gie.2018.07.007","volume":"89","author":"R Bell","year":"2018","unstructured":"Bell R, Lipham J, Louie B, Williams V, Luketich J, Hill M, Richards W, Dunst C, Lister D, McDowell-Jacobs L (2018) Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial. Gastrointest Endosc 89:14\u201322","journal-title":"Gastrointest Endosc"},{"key":"6916_CR13","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s00464-015-4659-y","volume":"30","author":"HF Warren","year":"2016","unstructured":"Warren HF, Reynolds JL, Lipham JC, Zehetner J, Bildzukewicz NA, Taiganides PA, Mickley J, Aye RW, Farivar AS, Louie BE (2016) Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc 30:3289\u20133296","journal-title":"Surg Endosc"},{"key":"6916_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jamcollsurg.2015.02.025","volume":"221","author":"JL Reynolds","year":"2015","unstructured":"Reynolds JL, Zehetner J, Wu P, Shah S, Bildzukewicz N, Lipham JC (2015) Laparoscopic magnetic sphincter augmentation versus laparoscopic nissen fundoplication: a matched-pair analysis of 100 patients. J Am Coll Surg 221:123\u2013128","journal-title":"J Am Coll Surg"},{"key":"6916_CR15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00464-014-3772-7","volume":"29","author":"M Riegler","year":"2015","unstructured":"Riegler M, Schoppman SF, Bonavina L, Ashton D, Horbach T, Kemen M (2015) Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: 1-year results of a multicenter, prospective observational study. Surg Endosc 29:1123\u20131129","journal-title":"Surg Endosc"},{"key":"6916_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","volume":"17","author":"SD Sullivan","year":"2014","unstructured":"Sullivan SD, Mauskopf JA, Augustovski F, Caro JJ, Lee KM, Minchin M, Orlewska E, Penna P, Barrios J-MR, Shau W-Y (2014) Budget impact analysis\u2014principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health 17:5\u201314","journal-title":"Value Health"},{"key":"6916_CR17","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/ajg.2009.312","volume":"104","author":"HB El-Serag","year":"2009","unstructured":"El-Serag HB, Fitzgerald S, Richardson P (2009) The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol 104:2161","journal-title":"Am J Gastroenterol"},{"key":"6916_CR18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-230X-13-12","volume":"13","author":"A Kandulski","year":"2013","unstructured":"Kandulski A, Peitz U, M\u00f6nkem\u00fcller K, Neumann H, Weigt J, Malfertheiner P (2013) GERD assessment including pH metry predicts a high response rate to PPI standard therapy. BMC Gastroenterol 13:12","journal-title":"BMC Gastroenterol"},{"key":"6916_CR19","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s00464-012-2602-z","volume":"27","author":"DA Kleiman","year":"2013","unstructured":"Kleiman DA, Sporn MJ, Beninato T, Metz Y, Crawford C, Fahey TJ, Zarnegar R (2013) Early referral for 24-h esophageal pH monitoring may prevent unnecessary treatment with acid-reducing medications. Surg Endosc 27:1302\u20131309","journal-title":"Surg Endosc"},{"key":"6916_CR20","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/ajg.2009.646","volume":"105","author":"VM Kushnir","year":"2010","unstructured":"Kushnir VM, Sayuk GS, Gyawali CP (2010) Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain. Am J Gastroenterol 105:1032","journal-title":"Am J Gastroenterol"},{"key":"6916_CR21","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/ajg.2011.180","volume":"106","author":"BE Lacy","year":"2011","unstructured":"Lacy BE, Chehade R, Crowell MD (2011) A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11). Am J Gastroenterol 106:1604","journal-title":"Am J Gastroenterol"},{"key":"6916_CR22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.cgh.2014.08.029","volume":"13","author":"A Patel","year":"2015","unstructured":"Patel A, Sayuk GS, Gyawali CP (2015) Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 13:884\u2013891","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6916_CR23","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s11605-009-0930-7","volume":"13","author":"S Ayazi","year":"2009","unstructured":"Ayazi S, Hagen JA, Chan LS, DeMeester SR, Lin MW, Ayazi A, Leers JM, Oezcelik A, Banki F, Lipham JC (2009) Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg 13:1440\u20131447","journal-title":"J Gastrointest Surg"},{"key":"6916_CR24","first-page":"37","volume":"57","author":"PR de Miranda Gomes","year":"2010","unstructured":"de Miranda Gomes PR, Pereira de Rosa AR, Sakae T, Simi\u0107 A, Gurski RR (2010) Correlation between pathological distal esophageal acid exposure and ineffective esophageal motility. Acta Chir Iugosl 57:37\u201343","journal-title":"Acta Chir Iugosl"},{"key":"6916_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00000658-199207000-00006","volume":"216","author":"HJ Stein","year":"1992","unstructured":"Stein HJ, Barlow AP, Demeester TR, Hinder RA (1992) Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid\/alkaline exposure, and duodenogastric reflux. Ann Surg 216:35","journal-title":"Ann Surg"},{"key":"6916_CR26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0002-9610(88)80266-6","volume":"155","author":"G Zaninotto","year":"1988","unstructured":"Zaninotto G, DeMeester TR, Schwizer W, Johansson K-E, Cheng S-C (1988) The lower esophageal sphincter in health and disease. Am J Surg 155:104\u2013111","journal-title":"Am J Surg"},{"key":"6916_CR27","unstructured":"US Census Bureau (2018) Population in the US"},{"key":"6916_CR28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/apt.13611","volume":"43","author":"F Khan","year":"2016","unstructured":"Khan F, Maradey-Romero C, Ganocy S, Frazier R, Fass R (2016) Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Pharmacol Ther 43:1124\u20131131","journal-title":"Aliment Pharmacol Ther"},{"key":"6916_CR29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1524-4733.2008.00399.x","volume":"12","author":"A Gosselin","year":"2009","unstructured":"Gosselin A, Luo R, Lohoues H, Toy E, Lewis B, Crawley J, Duh MS (2009) The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease. Value Health 12:34\u201339","journal-title":"Value Health"},{"key":"6916_CR30","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s00464-016-5370-3","volume":"31","author":"D Skubleny","year":"2017","unstructured":"Skubleny D, Switzer NJ, Dang J, Gill RS, Shi X, de Gara C, Birch DW, Wong C, Hutter MM, Karmali S (2017) LINX\u00ae magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis. Surg Endosc 31:3078\u20133084","journal-title":"Surg Endosc"},{"key":"6916_CR31","unstructured":"Centers for Medicare & Medicaid Services (CMS) (2015) Inpatient Charge Data FY 2015"},{"key":"6916_CR32","unstructured":"Centers for Medicare & Medicaid Services (CMS) (2018) Hospital Outpatient Prospective Payment System (OPPS)"},{"key":"6916_CR33","unstructured":"Centers for Medicare & Medicaid Services (CMS) (2018) Physician Fee Schedule"},{"key":"6916_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-227X-12-15","volume":"12","author":"Z Karaca","year":"2012","unstructured":"Karaca Z, Wong HS, Mutter RL (2012) Duration of patients\u2019 visits to the hospital emergency department. BMC Emerg Med 12:15","journal-title":"BMC Emerg Med"},{"key":"6916_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/POR.S36704","volume":"3","author":"N-O St\u00e5lhammar","year":"2012","unstructured":"St\u00e5lhammar N-O, Spiegel BM, L\u00f6fman HG, Karlsson M, Wahlqvist P, N\u00e6sdal J, Nelson MT, Despi\u00e9gel N (2012) Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA. Pragmat Obs Res 3:57","journal-title":"Pragmat Obs Res"},{"key":"6916_CR36","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s00464-014-3929-4","volume":"29","author":"I Ismail","year":"2015","unstructured":"Ismail I, Wolff S, Gronfier A, Mutter D, Swantr\u00f6m LL (2015) A cost evaluation methodology for surgical technologies. Surg Endosc 29:2423\u20132432","journal-title":"Surg Endosc"},{"key":"6916_CR37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/074880680502200104","volume":"22","author":"RD Shippert","year":"2005","unstructured":"Shippert RD (2005) A study of time-dependent operating room fees and how to save $100 000 by using time-saving products. Am J Cosmet Surg 22:25\u201334","journal-title":"Am J Cosmet Surg"},{"key":"6916_CR38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/CEOR.S112762","volume":"8","author":"M Corral","year":"2016","unstructured":"Corral M, Ferko N, Hogan A, Hollmann SS, Gangoli G, Jamous N, Batiller J, Kocharian R (2016) A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding. ClinicoEcon Outcomes Res 8:507","journal-title":"ClinicoEcon Outcomes Res"},{"key":"6916_CR39","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jhm.2208","volume":"9","author":"FR Ernst","year":"2014","unstructured":"Ernst FR, Chen E, Lipkin C, Tayama D, Amin AN (2014) Comparison of hospital length of stay, costs, and readmissions of alteplase versus catheter replacement among patients with occluded central venous catheters. J Hosp Med 9:490\u2013496","journal-title":"J Hosp Med"},{"key":"6916_CR40","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.21037\/jtd.2017.11.109","volume":"9","author":"F Zaraca","year":"2017","unstructured":"Zaraca F, Vaccarili M, Zaccagna G, Maniscalco P, Dolci G, Feil B, Perkmann R, Bertolaccini L, Crisci R (2017) Cost-effectiveness analysis of sealant impact in management of moderate intraoperative alveolar air leaks during video-assisted thoracoscopic surgery lobectomy: a multicentre randomised controlled trial. J Thorac Dis 9:5230","journal-title":"J Thorac Dis"},{"key":"6916_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/CEOR.S121230","volume":"9","author":"KJ Tomaszewski","year":"2017","unstructured":"Tomaszewski KJ, Ferko N, Hollmann SS, Eng SC, Richard HM, Rowe L, Sproule S (2017) Time and resources of peripherally inserted central catheter insertion procedures: a comparison between blind insertion\/chest X-ray and a real time tip navigation and confirmation system. ClinicoEcon Outcomes Res 9:115","journal-title":"ClinicoEcon Outcomes Res"},{"key":"6916_CR42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/CEOR.S164747","volume":"10","author":"H Cheng","year":"2018","unstructured":"Cheng H, Clymer JW, Qadeer RA, Ferko N, Sadeghirad B, Cameron CG, Amaral JF (2018) Procedure costs associated with the use of harmonic devices compared to conventional techniques in various surgeries: a systematic review and meta-analysis. ClinicoEcon Outcomes Res 10:399","journal-title":"ClinicoEcon Outcomes Res"},{"key":"6916_CR43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3111\/13696998.2016.1168826","volume":"19","author":"H Cheng","year":"2016","unstructured":"Cheng H, Soleas IM, Ferko NC, Cameron CG, Clymer JW, Amaral JF (2016) Hospital costs associated with thyroidectomy performed with a harmonic device compared to conventional techniques: a systematic review and meta-analysis. J Med Econ 19:750\u2013758","journal-title":"J Med Econ"},{"key":"6916_CR44","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cgh.2015.05.028","volume":"14","author":"RA Ganz","year":"2016","unstructured":"Ganz RA, Edmundowicz SA, Taiganides PA, Lipham JC, Smith CD, DeVault KR, Horgan S, Jacobsen G, Luketich JD, Smith CC (2016) Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol 14:671\u2013677","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6916_CR45","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/lap.2015.0394","volume":"25","author":"G Saino","year":"2015","unstructured":"Saino G, Bonavina L, Lipham JC, Dunn D, Ganz RA (2015) Magnetic sphincter augmentation for gastroesophageal reflux at 5\u00a0years: final results of a pilot study show long-term acid reduction and symptom improvement. J Laparoendosc Adv Surg Tech 25:787\u2013792","journal-title":"J Laparoendosc Adv Surg Tech"},{"key":"6916_CR46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1308\/rcsann.2017.0224","volume":"100","author":"D Prakash","year":"2018","unstructured":"Prakash D, Campbell B, Wajed S (2018) Introduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux\u2013results and challenges. Ann R Coll Surg Engl 100:251\u2013256","journal-title":"Ann R Coll Surg Engl"},{"key":"6916_CR47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00464-017-5696-5","volume":"32","author":"HF Warren","year":"2018","unstructured":"Warren HF, Brown LM, Mihura M, Farivar AS, Aye RW, Louie BE (2018) Factors influencing the outcome of magnetic sphincter augmentation for chronic gastroesophageal reflux disease. Surg Endosc 32:405\u2013412","journal-title":"Surg Endosc"},{"key":"6916_CR48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jamcollsurg.2013.04.039","volume":"217","author":"L Bonavina","year":"2013","unstructured":"Bonavina L, Saino G, Bona D, Sironi A, Lazzari V (2013) One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6\u00a0years of clinical experience from a single center. J Am Coll Surg 217:577\u2013585","journal-title":"J Am Coll Surg"},{"key":"6916_CR49","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1007\/s00464-012-2289-1","volume":"26","author":"JC Lipham","year":"2012","unstructured":"Lipham JC, DeMeester TR, Ganz RA, Bonavina L, Saino G, Dunn DH, Fockens P, Bemelman W (2012) The LINX\u00ae reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc 26:2944\u20132949","journal-title":"Surg Endosc"},{"key":"6916_CR50","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40273-016-0426-8","volume":"34","author":"J Mauskopf","year":"2016","unstructured":"Mauskopf J, Earnshaw S (2016) A methodological review of US budget-impact models for new drugs. Pharmacoeconomics 34:1111\u20131131","journal-title":"Pharmacoeconomics"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-019-06916-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00464-019-06916-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-019-06916-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T01:18:20Z","timestamp":1664500700000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00464-019-06916-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["6916"],"URL":"https:\/\/doi.org\/10.1007\/s00464-019-06916-6","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"assertion":[{"value":"16 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Drs. John Pandolfino and John Lipham act as advisors to Ethicon Inc. and have received funding for surgeon teaching and consulting on product development. Nicole Ferko, Andrew Hogan, and Rana Qadeer are employees of Cornerstone Research Group Inc. and have received funding from Ethicon Inc. to conduct the study. Amarpreet Chawla is a paid full-time employee of Ethicon Inc., manufacturer of the LINX Reflux Management System. John Pandolfino, John Lipham, Amarpreet Chawla, Nicole Ferko, Andrew Hogan, Rana A. Qadeer have no other conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}